mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.02 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |